Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Healthcare Biotechnology
Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Man! Interest In This Stock Is Jumping!
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(751)
•••
Comment by Finallytherockon Jul 17, 2021 12:28pm
139 Views
Post# 33565205

RE:RE:RE:RE:RE:RE:Man! Interest In This Stock Is Jumping!

RE:RE:RE:RE:RE:RE:Man! Interest In This Stock Is Jumping!Agreed, Craig Henry. It's sad and pathetic that for the last 10 years, the company continues to spin its wheels, seemingly accomplishing nothing. We have even entered the clinic after all of these years which is pathetic. If prothena and chiasi were not here, I'd not only invest here but I'd think the company is a scam. The ceo continues to fail at delivering. Most longs seem to have sold and moved on or at least no longer follow the company as much. Where's JD or prophet? Maybe they gave up too. Someone needs to hold the ceo accountable. The recent marketing campaign has been a bust. There was no detail on the data just released and let's face it, it's very very early data. Our only hope is that chiasi or prothena comes to the rescue. Maybe if the platform is truly great, others will come in but I am not holding my breath. This company has been a total failure for the last 10 years. The stock price is in the dumps, there's no interest, no volume and I am a shareholder feeling this way 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities